17
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Using human induced pluripotent stem cells to model cerebellar disease: Hope and hype

      other

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The cerebellum forms a highly ordered and indispensible component of motor function within the adult neuraxis, consisting of several distinct cellular subtypes. Cerebellar disease, through a variety of genetic and acquired causes, results in the loss of function of defined subclasses of neurons, and remains a significant and untreatable health care burden. The scarcity of therapies in this arena can partially be explained by unresolved disease mechanisms due to inaccessibility of human cerebellar neurons in a relevant experimental context where initiating disease mechanisms could be functionally elucidated, or drug screens conducted. In this review we discuss the potential promise of human induced pluripotent stem cells (hiPSCs) for regenerative neurology, with a particular emphasis on in vitro modelling of cerebellar degeneration. We discuss progress made thus far using hiPSC-based models of neurodegeneration, noting the relatively slower pace of discovery made in modelling cerebellar dysfunction. We conclude by speculating how strategies attempting cerebellar differentiation from hiPSCs can be refined to allow the generation of accurate disease models. This in turn will permit a greater understanding of cerebellar pathophysiology to inform mechanistically rationalised therapies, which are desperately needed in this field.

          Related collections

          Most cited references104

          • Record: found
          • Abstract: found
          • Article: not found

          Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

          Successful reprogramming of differentiated human somatic cells into a pluripotent state would allow creation of patient- and disease-specific stem cells. We previously reported generation of induced pluripotent stem (iPS) cells, capable of germline transmission, from mouse somatic cells by transduction of four defined transcription factors. Here, we demonstrate the generation of iPS cells from adult human dermal fibroblasts with the same four factors: Oct3/4, Sox2, Klf4, and c-Myc. Human iPS cells were similar to human embryonic stem (ES) cells in morphology, proliferation, surface antigens, gene expression, epigenetic status of pluripotent cell-specific genes, and telomerase activity. Furthermore, these cells could differentiate into cell types of the three germ layers in vitro and in teratomas. These findings demonstrate that iPS cells can be generated from adult human fibroblasts.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Cerebral organoids model human brain development and microcephaly

            The complexity of the human brain has made it difficult to study many brain disorders in model organisms, and highlights the need for an in vitro model of human brain development. We have developed a human pluripotent stem cell-derived 3D organoid culture system, termed cerebral organoid, which develops various discrete though interdependent brain regions. These include cerebral cortex containing progenitor populations that organize and produce mature cortical neuron subtypes. Furthermore, cerebral organoids recapitulate features of human cortical development, namely characteristic progenitor zone organization with abundant outer radial glial stem cells. Finally, we use RNAi and patient-specific iPS cells to model microcephaly, a disorder that has been difficult to recapitulate in mice. We demonstrate premature neuronal differentiation in patient organoids, a defect that could explain the disease phenotype. Our data demonstrate that 3D organoids can recapitulate development and disease of even this most complex human tissue.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Human induced pluripotent stem cells free of vector and transgene sequences.

              Reprogramming differentiated human cells to induced pluripotent stem (iPS) cells has applications in basic biology, drug development, and transplantation. Human iPS cell derivation previously required vectors that integrate into the genome, which can create mutations and limit the utility of the cells in both research and clinical applications. We describe the derivation of human iPS cells with the use of nonintegrating episomal vectors. After removal of the episome, iPS cells completely free of vector and transgene sequences are derived that are similar to human embryonic stem (ES) cells in proliferative and developmental potential. These results demonstrate that reprogramming human somatic cells does not require genomic integration or the continued presence of exogenous reprogramming factors and removes one obstacle to the clinical application of human iPS cells.
                Bookmark

                Author and article information

                Journal
                J Neurogenet
                J. Neurogenet
                INEG
                ineg20
                Journal of Neurogenetics
                Informa Healthcare
                0167-7063
                1563-5260
                3 July 2015
                27 August 2015
                : 29
                : 2-3
                : 95-102
                Affiliations
                [ a ]National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology , London, UK
                [ b ]Center for Neurology and Hertie Institute for Clinical Brain Research, Eberhard-Karls-University , Tübingen, Germany
                [ c ]Department of Molecular Neuroscience and Queen Square Brain Bank, UCL Institute of Neurology , London, UK
                [ d ]Department of Clinical Neurosciences, University of Cambridge , Cambridge, UK
                [ e ]Euan MacDonald Centre for MND, University of Edinburgh , Edinburgh, UK
                Author notes
                [* ]

                These authors contributed equally to this work.

                Address correspondence to Sarah Wiethoff, MD, Rickie Patani, MD, MRCP, PhD, National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology , 33 Queen Square, WC1N 3BG London, UK. Tel: + 020 7837 3611. E-mail: s.wiethoff.12@ 123456ucl.ac.uk . Tel: + 00 44 (0)20 7679 4264. E-mail: rickie.patani@ 123456ucl.ac.uk
                Article
                1053478
                10.3109/01677063.2015.1053478
                4673530
                25985846
                3fb860f6-8ff3-488b-9ab9-0ebd00fa2336
                © 2015 The Author(s). Published by Taylor & Francis

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 27 February 2015
                : 18 May 2015
                Page count
                Figures: 2, Tables: 0, Equations: 0, References: 100, Pages: 8
                Categories
                Review
                Review Article

                Genetics
                cerebellum,directed differentiation,disease modelling,ipsc-technology,reprogramming
                Genetics
                cerebellum, directed differentiation, disease modelling, ipsc-technology, reprogramming

                Comments

                Comment on this article